MA33830B1 - Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide secondaires - Google Patents

Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide secondaires

Info

Publication number
MA33830B1
MA33830B1 MA34973A MA34973A MA33830B1 MA 33830 B1 MA33830 B1 MA 33830B1 MA 34973 A MA34973 A MA 34973A MA 34973 A MA34973 A MA 34973A MA 33830 B1 MA33830 B1 MA 33830B1
Authority
MA
Morocco
Prior art keywords
hydroxyquinoline
compounds
novel
carboxamide
candida
Prior art date
Application number
MA34973A
Other languages
Arabic (ar)
English (en)
Inventor
Stefania Gagliardi
Sordo Simone Del
Federico Mailland
Michela Legora
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42025709&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33830(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of MA33830B1 publication Critical patent/MA33830B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Cette invention concerne de nouveaux dérivés de 8-hydroxyquinoline- 7-carboxamide secondaires de formule générale (i) et leurs sels pharmaceutiquement acceptables. Ces composés sont utiles en tant qu'agents antifongiques. Plus spécifiquement, ces composés ont été testés contre tricophyton rubrum, tricophyton mentagrophytes, aspergillus niger et scopulariopsis brevicaulis. Beaucoup de ces composés sont actifs contre l'espèce candida, par exemple, candida albicans et candida glabrata.
MA34973A 2009-12-29 2012-06-15 Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide secondaires MA33830B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09180895A EP2345641A1 (fr) 2009-12-29 2009-12-29 Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide secondaire
PCT/EP2010/070793 WO2011080266A1 (fr) 2009-12-29 2010-12-28 Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide secondaires

Publications (1)

Publication Number Publication Date
MA33830B1 true MA33830B1 (fr) 2012-12-03

Family

ID=42025709

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34973A MA33830B1 (fr) 2009-12-29 2012-06-15 Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide secondaires

Country Status (38)

Country Link
US (1) US8729076B2 (fr)
EP (2) EP2345641A1 (fr)
JP (1) JP5755245B2 (fr)
KR (1) KR20120097407A (fr)
CN (1) CN102712596B (fr)
AU (1) AU2010338269B2 (fr)
BR (1) BR112012015732A2 (fr)
CA (1) CA2783230A1 (fr)
CL (1) CL2012001759A1 (fr)
CO (1) CO6561775A2 (fr)
CY (1) CY1115060T1 (fr)
DK (1) DK2519504T3 (fr)
DO (1) DOP2012000185A (fr)
EA (1) EA020487B1 (fr)
EC (1) ECSP12012008A (fr)
ES (1) ES2460626T3 (fr)
GE (1) GEP20156269B (fr)
GT (1) GT201200214A (fr)
HR (1) HRP20140348T1 (fr)
IL (1) IL220307A (fr)
MA (1) MA33830B1 (fr)
ME (1) ME01748B (fr)
MX (1) MX2012007746A (fr)
MY (1) MY162548A (fr)
NI (1) NI201200115A (fr)
NZ (1) NZ600782A (fr)
PE (1) PE20121804A1 (fr)
PH (1) PH12012501325A1 (fr)
PL (1) PL2519504T3 (fr)
PT (1) PT2519504E (fr)
RS (1) RS53303B (fr)
SG (1) SG181588A1 (fr)
SI (1) SI2519504T1 (fr)
SM (1) SMT201400059B (fr)
TN (1) TN2012000319A1 (fr)
UA (1) UA109422C2 (fr)
WO (1) WO2011080266A1 (fr)
ZA (1) ZA201204349B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345643A1 (fr) * 2009-12-29 2011-07-20 Polichem S.A. Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide et leurs utilisations
EP2345642A1 (fr) * 2009-12-29 2011-07-20 Polichem S.A. Dérivés de 8-hydroxyquinoline-7-carboxamide secondaire pour une utilisation en tant qu'agents antifongiques
CN104805147B (zh) * 2014-01-26 2018-01-05 上海医药工业研究院 一种二噁英类化合物的制备方法、纯化方法及应用
MX2022010804A (es) 2020-03-04 2023-01-16 Amplyx Pharmaceuticals Inc Uso de compuestos en el tratamiento de infecciones fungicas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326330A (en) 1885-09-15 Harness-support
US326328A (en) 1885-09-15 Broiler
DE540842C (de) 1930-08-06 1931-12-28 Chinosol Fabrik Akt Ges Verfahren zur Darstellung der 8-Acetyloxychinolin-7-carbonsaeure
FR2160718A1 (en) * 1971-11-23 1973-07-06 Roussel Uclaf 7-benzyl aminomethyl-8-hydroxy quinolines - bacteriostats and fungistats
DE3426995A1 (de) 1984-07-21 1986-01-30 Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart Halterung einer scheibe, vorzugsweise einer windschutzscheibe
CN1180995A (zh) 1995-04-08 1998-05-06 巴斯福股份公司 防治有害真菌的方法
AU4172197A (en) * 1996-09-10 1998-04-02 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
EP1326865B1 (fr) 2000-10-12 2009-05-06 Merck & Co., Inc. Aza- et polyaza-naphthalenyl carboxamides utiles comme inhibiteurs de l'integrase du vih
AU1532802A (en) 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
CN1659143A (zh) 2001-03-01 2005-08-24 盐野义制药株式会社 具有hiv整合酶抑制活性的含氮杂芳基化合物
ATE404537T1 (de) 2002-08-13 2008-08-15 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
FR2889192A1 (fr) * 2005-07-27 2007-02-02 Cytomics Systems Sa Composes antifongiques, compositions contenant ces composes et leurs utilisations
EP2079699A1 (fr) * 2006-07-25 2009-07-22 Envivo Pharmaceuticals, Inc. Dérivés de quinoline
EP2345642A1 (fr) * 2009-12-29 2011-07-20 Polichem S.A. Dérivés de 8-hydroxyquinoline-7-carboxamide secondaire pour une utilisation en tant qu'agents antifongiques
EP2345643A1 (fr) * 2009-12-29 2011-07-20 Polichem S.A. Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide et leurs utilisations

Also Published As

Publication number Publication date
EP2519504A1 (fr) 2012-11-07
US8729076B2 (en) 2014-05-20
MY162548A (en) 2017-06-15
NZ600782A (en) 2013-11-29
PL2519504T3 (pl) 2014-08-29
EA020487B1 (ru) 2014-11-28
EA201270672A1 (ru) 2012-12-28
TN2012000319A1 (en) 2013-12-12
JP2013515757A (ja) 2013-05-09
EP2345641A1 (fr) 2011-07-20
ME01748B (me) 2014-09-20
EP2519504B1 (fr) 2014-03-19
HK1178525A1 (en) 2013-09-13
UA109422C2 (xx) 2015-08-25
ECSP12012008A (es) 2012-08-31
SI2519504T1 (sl) 2014-05-30
KR20120097407A (ko) 2012-09-03
NI201200115A (es) 2013-04-22
PE20121804A1 (es) 2013-01-17
DK2519504T3 (da) 2014-05-05
HRP20140348T1 (hr) 2014-05-23
CL2012001759A1 (es) 2012-12-07
US20120316167A1 (en) 2012-12-13
CA2783230A1 (fr) 2011-07-07
AU2010338269A2 (en) 2012-08-02
ES2460626T3 (es) 2014-05-14
MX2012007746A (es) 2012-08-03
ZA201204349B (en) 2013-08-28
CY1115060T1 (el) 2016-12-14
SMT201400059B (it) 2014-07-07
PH12012501325A1 (en) 2013-01-07
BR112012015732A2 (pt) 2019-09-24
IL220307A (en) 2015-04-30
WO2011080266A1 (fr) 2011-07-07
AU2010338269A1 (en) 2012-07-19
PT2519504E (pt) 2014-04-14
JP5755245B2 (ja) 2015-07-29
CN102712596B (zh) 2014-04-09
CO6561775A2 (es) 2012-11-15
DOP2012000185A (es) 2013-01-15
GT201200214A (es) 2013-09-04
GEP20156269B (en) 2015-04-14
RS53303B (sr) 2014-08-29
IL220307A0 (en) 2012-08-30
SG181588A1 (en) 2012-07-30
CN102712596A (zh) 2012-10-03
AU2010338269B2 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
MA33829B1 (fr) Nouveaux dérivés de 8-hydroxyquinoline-7-carboxamide tertiaires et leurs utilisations
MA31080B1 (fr) Dérivés cyclisés en tant qu'inhibiteurs d'eg-5.
MA34644B1 (fr) Dérivés de pyrazole aminopyrimidine en tant que modulateurs du lrrk2
MA34342B1 (fr) Dérivés de la pipéridinone en tant qu'inhibiteurs de mdm2 pour le traitement du cancer
MA31574B1 (fr) Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf
MA33364B1 (fr) Dérivés aminobutyriques substitués en tant qu'inhibiteurs de néprilysine
MA40225B1 (fr) Composés dihydroisoquinolinone substitués
HN2012001744A (es) Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6
MA33384B1 (fr) Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant
MA38461A1 (fr) Inhibiteurs de la voie de la kynurénine
UA107455C2 (uk) Похідні індолу як протиракові агенти
MA33828B1 (fr) Dérivés 8-hydroxyquinoline-7-carboxamide secondaires et leurs utilisations en tant qu'agents antifongiques
DOP2012000185A (es) Nuevos derivados secundarios de 8-hidroxiquinolina-7-carboxamida
MA30882B1 (fr) Derives d'acides vinylogues en tant qu'inhibiteur de la chymase
MA37872A1 (fr) Sels de composé benzothiazolone utilisés en tant qu'agoniste de beta-2-adrenoceptor
MA38838A1 (fr) Dérivés de pipéridinyl-indole et leur utilisation en tant qu'inhibiteurs du facteur b du complément